"City of Hope Corona provides the community with unparalleled care and innovative treatments close to home. Our light and bright 7,000-square-foot facility features several exam rooms, an infusion center and a radiation treatment room, expanding access to City of Hope’s world-class level of care. Our skilled and compassionate physicians and medical staff specialize in hematology, medical oncology, outpatient chemotherapy, PET (positron emission tomography) and CT (computed tomography) imaging and radiation therapy. We also offer consultations."

During the past decade, City of Hope Corona conducted 30 clinical trials. In the 10-year time frame, 30 clinical trials started and 17 clinical trials were completed, i.e. on average, 56.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 17 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "City of Hope Corona" #1 sponsor was "SWOG Cancer Research Network" with 12 trials, followed by "National Cancer Institute (NCI)" with 8 trials sponsored, "City of Hope Medical Center" with 7 trials sponsored, "Alliance for Clinical Trials in Oncology" with 4 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 4 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "City of Hope Corona" #1 collaborator was "National Cancer Institute (NCI)" with 23 trials as a collaborator, "Canadian Cancer Trials Group" with 3 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Bayer" with 1 trials as a collaborator and "Halozyme Therapeutics" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "City of Hope Corona" are "Recurrent Squamous Cell Lung Carcinoma" (6 trials), "Stage IV Breast Cancer AJCC v6 and v7" (5 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (5 trials), "HER2/Neu Negative" (4 trials) and "Stage IIIA Lung Non-Small Cell Cancer AJCC v7" (4 trials). Many other conditions were trialed in "City of Hope Corona" in a lesser frequency.

Most popular intervention types in "City of Hope Corona" are "Drug" (27 trials), "Other" (26 trials), "Biological" (13 trials), "Procedure" (6 trials) and "Radiation" (5 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (20 trials), "Pembrolizumab" (6 trials), "Nivolumab" (5 trials), "Quality-of-Life Assessment" (5 trials) and "Questionnaire Administration" (5 trials). Other intervention names were less common.

The vast majority of trials in "City of Hope Corona" are 29 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "City of Hope Corona". undefined are not yet recruiting, 3 are recruiting, 21 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in City of Hope Corona, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in City of Hope Corona, 5 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".